Historical record - last NADAC effective date: 12/22/2021
Product Information
PROGESTERONE 100 MG CAPSULE is a generic product labeled by Bionpharma Inc., priced at $0.2578 per EA under NDC 69452014820. Its NADAC has been published 262 times since Dec 21, 2016.
FDA first approved this application on Aug 16, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Bionpharma Inc.NDC
69452014820
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
12/22/2021
Active Ingredients
PROGESTERONEApproval Type
Generic (ANDA)
FDA Application
ANDA200900FDA Approved
8/16/2013
TE Code
AB
On Market Since
9/20/2016
Pharmacological Classes
Price Statistics
The NADAC for PROGESTERONE 100 MG CAPSULE has been published 262 times since Dec 21, 2016, and over the history we have for it it has declined 74.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2578 per EA |
|---|---|
| All-time high | $1.0224 (Jan 11, 2017) |
| All-time low | $0.2489 (Nov 17, 2021) |
| Median price | $0.4891 |
| Average price | $0.5080 |
| Largest weekly change | +25.8% (May 22, 2019) |
| Weeks tracked | 262 |
| Tracking since | Dec 21, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+0.2%
All
-74.8%
Last surveyed Dec 22, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bionpharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PROGESTERONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progesterone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROGESTERONE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PROGESTERONE 100 MG CAPSULE, manufactured by Bionpharma Inc., is $0.2578 per EA (NDC 69452014820), effective Dec 22, 2021.
How has the price of PROGESTERONE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PROGESTERONE 100 MG CAPSULE has declined 74.8%. It has been tracked across 262 weekly CMS publications since Dec 21, 2016.
What are the highest and lowest recorded NADAC prices for PROGESTERONE 100 MG CAPSULE?
Since Dec 21, 2016, the NADAC for PROGESTERONE 100 MG CAPSULE has ranged from a low of $0.2489 (Nov 17, 2021) to a high of $1.0224 (Jan 11, 2017), with a median of $0.4891 per EA.
Are there cheaper alternatives to PROGESTERONE 100 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PROGESTERONE 100 MG CAPSULE, is $0.2290 per EA — about 11% below PROGESTERONE 100 MG CAPSULE.
Who manufactures PROGESTERONE 100 MG CAPSULE?
PROGESTERONE 100 MG CAPSULE (NDC 69452014820) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.